Target intelligence / Profile preview

E3 ubiquitin-protein ligase (generic; no unique full name for “homolog X”) (E3 (generic); no unique abbreviation for “homolog X”)

Target
E3 (generic); no unique abbreviation for “homolog X”
Molecular classification
Enzyme, Ubiquitin-proteasome system (UPS) component, HECT-type E3 ubiquitin ligase (if inferred), RING-type E3 ubiquitin ligase (if inferred), RBR-type E3 ubiquitin ligase (if inferred)
01

Overview

E3 ubiquitin ligases are a large family of enzymes that catalyze the covalent attachment of ubiquitin to substrate lysine residues, marking proteins for proteasomal degradation or regulating their activity and localization. Three major subclasses exist based on catalytic mechanism: HECT domain-containing, RING finger domain-containing, and RBR family. E3 ligases control the specificity of substrate recognition in ubiquitination, and play key roles in regulation of protein turnover, signal transduction, cell cycle checkpoints, apoptosis, and immune responses. Many members are implicated in disease processes, including cancer and neurodegeneration, and targeted by novel therapeutic approaches such as PROTACs. However, the designation “E3 ubiquitin-protein ligase homolog X” does not correspond to a precise, druggable protein target or biomarker. If you can provide a specific gene symbol, Uniprot ID, or standardized protein name, more precise targeted information can be retrieved.

Other names
E3 ubiquitin ligaseE3 ligaseHECT domain E3 ligase (if referring to HECT-type family member)RING-type E3 ligase (if referring to RING-type family member)RBR-type E3 ligase (if referring to RBR subfamily)
02

Mechanism of action

Targeted protein degradation by PROTACs which recruit E3 ligases. No specific mechanism for "homolog X"; mechanisms depend on family member.

03

Biological functions

Protein ubiquitinationProtein degradation via 26S proteasomeSignal transductionCell cycle regulationApoptosisDNA damage responseImmune response regulation
04

Disease associations

Cancer (many E3 ligases implicated but not "homolog X" specifically)Neurodegenerative disease (general family association)Infection (some family members involved)Other (cell differentiation, immune regulation)
05

Safety considerations

Off-target effects due to broad substrate specificity of many E3 ligasesPossible disruption of cellular protein homeostasisSpecific concerns depend on the actual E3 ligase targeted
06

Interacting drugs

PROTACs (proteolysis-targeting chimeras that recruit E3 ligases for target protein degradation)

1 more in the full profile.

07

Biomarkers

None specific to "E3 ubiquitin-protein ligase homolog X"Some E3 ligases can be biomarkers in cancer or immune disease

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase (generic; no unique full name for “homolog X”) (E3 (generic); no unique abbreviation for “homolog X”).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase (generic; no unique full name for “homolog X”) (E3 (generic); no unique abbreviation for “homolog X”).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call